What drugs does SAGENT make?

SAGENT has 11 FDA-approved drugs including NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE.

What therapeutic areas does SAGENT focus on?

SAGENT focuses primarily on Gastroenterology and Cardiovascular.

Data updated: Mar 10, 2026

SAGENT

GastroenterologyCardiovascular

Generics

SAGENT is a generic drug manufacturer focused on Gastroenterology, Cardiovascular. Key products include NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE.

1995

Since

Drugs

Trials

102

Approved (2yr)

Key Drugs

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

norepinephrine bitartrate

alpha-adrenergic receptor 1 indications · 2021

Recent Activity

DILTIAZEM HYDROCHLORIDE 2026-02-23

Labeling

DILTIAZEM HYDROCHLORIDE 2026-02-23

Labeling

GLYCOPYRROLATE 2026-02-10

Labeling

GLYCOPYRROLATE 2026-02-06

Labeling

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE 2026-02-06

Manufacturing (CMC)

BUMETANIDE 2026-02-05

DILTIAZEM HYDROCHLORIDE 2026-01-24

Labeling

DILTIAZEM HYDROCHLORIDE 2026-01-24

Labeling

GLYCOPYRROLATE 2026-01-19

Labeling

GLYCOPYRROLATE 2026-01-19

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 67%

2 drugs

Cardiovascular 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

BAUSCH specialty

Cardiovascular, Gastroenterology

APOTHECON specialty

Cardiovascular, Gastroenterology

VALIDUS PHARMS specialty

Cardiovascular, Gastroenterology

WAYLIS THERAP big-pharma

Cardiovascular, Gastroenterology

WARNER CHILCOTT LLC specialty

Cardiovascular, Gastroenterology

SAGENT

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (11)

Active (6)

Discontinued (5)

Company Info